Evidence map›Paper›PMID 33080873›Full record

ArticleBiomolecules2020

Metabolic Effects of Selective Deletion of Group VIA Phospholipase A

John Turk, Haowei Song, Mary Wohltmann, Cheryl Frankfater, Xiaoyong Lei, Sasanka Ramanadham

Open access · goldAbstract read
In one paragraph

Article in Biomolecules, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. The PNPLA family of enzymes: characterisation and biological role.Arhiv za higijenu rada i toksikologiju · 2023
    Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

John TurkMass Spectrometry Facility, Division of Endocrinology, Metabolism, and Lipid Research, Department of Medicine, Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Haowei SongMass Spectrometry Facility, Division of Endocrinology, Metabolism, and Lipid Research, Department of Medicine, Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Mary WohltmannMass Spectrometry Facility, Division of Endocrinology, Metabolism, and Lipid Research, Department of Medicine, Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Cheryl FrankfaterMass Spectrometry Facility, Division of Endocrinology, Metabolism, and Lipid Research, Department of Medicine, Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Xiaoyong LeiDepartment of Cell, Developmental, and Integrative Biology, Comprehensive Diabetes Center, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Sasanka RamanadhamDepartment of Cell, Developmental, and Integrative Biology, Comprehensive Diabetes Center, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Washington University in St. Louis · USUniversity of Alabama at Birmingham · US

Funding

Washington University Nutrition Obesity Research CenterP30DK056341 · NIDDK · WASHINGTON UNIVERSITY · PI Dominic N Reeds · 1999 to 2026
$30.2M
WU P&FP30DK020579 · NIDDK · WASHINGTON UNIVERSITY · PI Clay F. Semenkovich · 2013 to 2026
$27.1M
University of Alabama at Birmingham's Diabetes Research CenterP30DK079626 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BARBARA A GOWER · 2013 to 2026
$19.5M
YOGA LIFESTYLE INTERVENTION REDUCES BLOOD PRESSURE IN HIV-INFECTED ADULTSP41RR000954 · NCRR · WASHINGTON UNIVERSITY · PI BATEMAN, RANDALL J · 1985 to 2011
$16.0M
TrainingP41GM103422 · NIGMS · WASHINGTON UNIVERSITY · PI YARASHESKI, KEVIN E · 2012 to 2019
$12.0M
PHOSPHOLIPID-DERIVED MEDIATORS AND INSULIN SECRETIONR37DK034388 · NIDDK · WASHINGTON UNIVERSITY · PI TURK, JOHN W · 1993 to 2010
$4.9M
A Biomedical Mass Spectrometry Resource: Ongoing Driving Biomedical ProjectsR24GM136766 · NIGMS · WASHINGTON UNIVERSITY · PI GROSS, MICHAEL L · 2020 to 2022
$2.3M
Importance of immune-cell lipid signaling in events leading to type 1 diabetesR21AI146743 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI RAMANADHAM, SASANKA · 2019 to 2020
$408k
NCRR NIH HHS P41 RR000954NIAID NIH HHS R21 AI146743NIDDK NIH HHS P30 DK020579NIDDK NIH HHS P30 DK056341NIDDK NIH HHS P30 DK079626NIDDK NIH HHS R37 DK034388NIGMS NIH HHS P41 GM103422NIGMS NIH HHS R24 GM136766
6 · The paper itself

Abstract

To examine the role of group VIA phospholipase A

Indexed as

AnimalsBlood GlucoseDiet, High-FatGlucoseGlucose IntoleranceGlucose Tolerance TestGroup VI Phospholipases A2HumansInsulinInsulin-Secreting CellsInsulin SecretionIslets of LangerhansMacrophagesMiceMice, KnockoutPhospholipases A2Blood GlucoseGlucoseGroup VI Phospholipases A2InsulinPhospholipases A2Pla2g6 protein, mouseglucose tolerancegroup VIA phospholipase A2insulin resistanceinsulin secretionpancreatic isletsβ-cells

Identifiers

PMID33080873
PMCPMC7602969
OpenAlexW3093297978

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.